879 / 1224
/
Study
Patients
Median OS
LC
Hoyer
2005
Phase II
22
5.4
months
57% @ 6m
Koong
2005
Phase II
17
8.3
months
16 / 17
Schellenberg
2008
Phase II
16
11.4 months
81%
Schellenberg
2011
Phase II
20
11.8 months
94% @ 1a
ESTRO SBRT Course 2015 - Emerging SBRT indications
10
SBRT for locally advanced pancreatic cancer
• (Very) short OS – similar to systemic treatment only
• Interpretation of promising LC considering OS ?